[Multiple sclerosis and melanoma].
| Autor: | Lashch NY; Pirogov Russian National Research Medical University, Moscow, Russia., Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center for Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia., Dvornikov AS; Pirogov Russian National Research Medical University, Moscow, Russia., Gaydina TA; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center for Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia., Pavlicov AE; Pirogov Russian National Research Medical University, Moscow, Russia. |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (10), pp. 123-128. |
| DOI: | 10.17116/jnevro2023123101123 |
| Abstrakt: | Multiple sclerosis (MS) is a chronic autoimmune progressive demyelinating disease of the central nervous system, mainly in young people. The clinical picture of MS has a variety of neurological symptoms, which manifests itself during periods of exacerbation or progression and stabilizes at the moments of remission. The widespread introduction of new drugs with immunosuppressive and immunomodulatory mechanisms of action has led to the development of special risk management plans for monitoring patients during therapy and preventing adverse events and new comorbid conditions. This article presents a review of the literature and a case report on the combination of MS and melanoma in patients. Melanoma can rarely develop in patients treated with DMD, so it is necessary to introduce such a specialist in dermatology and venereology into a multidisciplinary team. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|